Devonian Health Group is trading 6.92% up at CA$8.50 after announcing on August 18, 2026, that it expects NYSE American trading to begin as early as August 21 under DHGR and DHGR WS.

  • The planned listing is tied to an underwritten public offering.
  • Trading requires final exchange approval.
  • The company will remain listed on the TSX Venture Exchange.